Learn how integrating autonomic and vascular screening into your podiatry practice can identify high-risk diabetic patients before complications arise.
Published October 2, 2026 · Updated November 5, 2026
For the podiatric practitioner, the management of diabetic foot complications remains one of the most critical challenges in daily clinical practice. Despite modern advancements in wound care, the incidence of diabetic foot ulcers (DFUs) and subsequent lower-extremity amputations continues to represent a significant burden on patient quality of life and healthcare resources. The paradigm shift must move from reactive wound management to proactive risk stratification through comprehensive diagnostic screening.
While podiatrists are experts at identifying structural deformities and mechanical pressure points, the underlying vascular and autonomic drivers of ulceration are frequently missed until a lesion has already formed. Peripheral arterial disease (PAD) in diabetes often presents as medial arterial calcification, which can render standard diagnostic tools less reliable. Furthermore, the role of autonomic dysfunction—specifically sudomotor denervation—contributes to anhidrosis, skin cracking, and the development of fissures that serve as portals of entry for infection.
Early vascular screening diabetes protocols are essential to detect subclinical changes in hemodynamics. By identifying peripheral arterial disease diabetes markers early, clinicians can intervene with medical management and vascular referrals before the progression to critical limb ischemia occurs.
US MedResources has developed the VitalScan ANS+ system to address these diagnostic gaps. This FDA-cleared, non-invasive platform integrates autonomic, cardiovascular, and vascular testing into a single 15-minute procedure. Designed for efficiency, it allows existing clinical staff to perform high-level diagnostics without the need for a specialized technician, ensuring that patient data is available for review before the patient leaves the office.
The VitalScan ANS+ measures critical markers that correlate with the American Diabetes Association (ADA) standards for foot care, including:
Implementation of the VitalScan ANS+ provides a dual benefit: enhanced clinical outcomes and improved practice revenue. Because the system provides automated interpretive reports, the podiatrist is empowered to discuss actionable data with the patient immediately during the consultation. This transparency encourages patient compliance with offloading, shoe-gear modification, and metabolic control.
From a practice management perspective, the integration of these tests aligns with current CPT billing pathways. Autonomic nervous system testing is eligible for billing under codes 95921-95924, while vascular studies can be billed under codes 93922-93971. This structure allows podiatry practices to offer a higher standard of care while ensuring financial sustainability for the added clinical time.
Clinical guidelines from the AHA, ACC, and ADA emphasize that diabetic neuropathy screening should be a routine component of every podiatric exam. When diagnostic testing moves beyond the 10-gram monofilament test to include quantitative metrics of the ANS, practitioners gain a more granular view of the patient’s risk profile. Understanding whether a patient has cardiac autonomic neuropathy (CAN) changes the systemic risk profile, signaling that the patient may also have impaired vascular autoregulation.
Integrating the VitalScan ANS+ system into your podiatry practice transforms foot ulcer prevention from a guessing game into a data-driven strategy. By conducting regular, non-invasive vascular screening and autonomic assessment, you can identify high-risk patients before the onset of symptomatic vascular insufficiency or skin breakdown. Leveraging these diagnostic tools not only supports superior clinical outcomes and reduced amputation rates but also optimizes your practice workflow through efficient, billable diagnostic testing.
One-Page Reference
Code descriptions, typical reimbursement ranges, ICD-10 pairings, and the CMS bundling note to check before you bill.
Your diabetic patients already need this. See what adding the tests to your existing visits produces per month.